We are live on ! Find out more
John Overdeck

John Overdeck Two Sigma Investments

AUM $138B Turnover 29.02%
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+21.14%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$138B
AUM Growth
+$14.2B
Cap. Flow
-$5.38B
Cap. Flow %
-3.9%
Top 10 Hldgs %
8.28%
Holding
5,589
New
1,050
Increased
1,919
Reduced
1,756
Closed
572
Avg Time Held Equity + Options
1.4 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
1.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$753M
2
BSX icon
Boston Scientific
BSX
+$540M
3
DOW icon
Dow Inc
DOW
+$485M
4
WFC icon
Wells Fargo
WFC
+$457M
5
GS icon
Goldman Sachs
GS
+$378M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$1.32B
2
NVDA icon
NVIDIA
NVDA
+$1.02B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$787M
4
SNDK icon
Sandisk
SNDK
+$744M
5
DELL icon
Dell
DELL
+$688M

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Financials 15.22%
3 Miscellaneous 12.05%
4 Healthcare 11.94%
5 Industrials 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RLMD icon
3201
Relmada Therapeutics
RLMD
$342M
$1.49M ﹤0.01%
214,915
-193,180
-47% -$1.35M
2022 Q1
17 quarters
CCJ icon
3202
PUT
Cameco
CCJ
$35.7B
$1.49M ﹤0.01%
14,600
-4,200
-22% -$471K
2025 Q4
2 quarters
USAR icon
3203
CALL
USA Rare Earth Inc
USAR
$3.84B
$1.48M ﹤0.01%
68,800
-41,400
-38% -$944K
2026 Q1
1 quarter
RRGB icon
3204
Red Robin
RRGB
$164M
$1.48M ﹤0.01%
+185,113
New +$822K
2026 Q2
0 quarters
WU icon
3205
Western Union
WU
$1.95B
$1.48M ﹤0.01%
191,930
-4,827,036
-96% -$40.5M
2020 Q3
23 quarters
ETV icon
3206
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.72B
$1.48M ﹤0.01%
99,309
– –
2025 Q3
3 quarters
GALT icon
3207
Galectin Therapeutics
GALT
$340M
$1.48M ﹤0.01%
318,245
-148,818
-32% -$386K
2025 Q3
3 quarters
AA icon
3208
CALL
Alcoa
AA
$10.7B
$1.48M ﹤0.01%
28,300
-6,800
-19% -$455K
2025 Q4
2 quarters
KMI icon
3209
CALL
Kinder Morgan
KMI
$75.6B
$1.47M ﹤0.01%
46,100
-13,900
-23% -$448K
2025 Q4
2 quarters
CHRD icon
3210
Chord Energy
CHRD
$8.25B
$1.47M ﹤0.01%
+12,892
New +$1.75M
2026 Q2
0 quarters
MFIC icon
3211
MidCap Financial Investment
MFIC
$674M
$1.47M ﹤0.01%
146,152
-102,369
-41% -$1.12M
2019 Q3
27 quarters
SMTC icon
3212
PUT
Semtech
SMTC
$13.2B
$1.47M ﹤0.01%
+9,100
New +$1.19M
2026 Q2
0 quarters
RWR icon
3213
State Street SPDR Dow Jones REIT ETF
RWR
$1.78B
$1.47M ﹤0.01%
13,000
-322,900
-96% -$35.4M
2025 Q4
2 quarters
ACNT icon
3214
Ascent Industries
ACNT
$124M
$1.47M ﹤0.01%
97,695
-34,798
-26% -$486K
2025 Q3
3 quarters
VFQY icon
3215
Vanguard US Quality Factor ETF
VFQY
$514M
$1.46M ﹤0.01%
8,600
-6,700
-44% -$1.08M
2026 Q1
1 quarter
LIVN icon
3216
LivaNova
LIVN
$4.32B
$1.46M ﹤0.01%
17,805
-29,922
-63% -$2.12M
2022 Q3
15 quarters
MOH icon
3217
CALL
Molina Healthcare
MOH
$11.2B
$1.46M ﹤0.01%
6,400
-800
-11% -$145K
2026 Q1
1 quarter
EPRX icon
3218
Eupraxia Pharmaceuticals
EPRX
$511M
$1.46M ﹤0.01%
221,084
+210,284
+1,947% +$1.45M
2026 Q1
1 quarter
MMYT icon
3219
MakeMyTrip
MMYT
$4.17B
$1.46M ﹤0.01%
27,400
-3,800
-12% -$173K
2024 Q4
6 quarters
STRZ icon
3220
Starz Entertainment Corp
STRZ
$420M
$1.46M ﹤0.01%
+50,592
New +$1.1M
2026 Q2
0 quarters
CWST icon
3221
Casella Waste Systems
CWST
$5.74B
$1.46M ﹤0.01%
15,052
+2,481
+20% +$212K
2025 Q4
2 quarters
ATI icon
3222
PUT
ATI
ATI
$24.6B
$1.46M ﹤0.01%
7,400
+4,000
+118% +$678K
2025 Q4
2 quarters
STLD icon
3223
Steel Dynamics
STLD
$35.5B
$1.46M ﹤0.01%
+6,355
New +$1.49M
2026 Q2
0 quarters
COGT icon
3224
Cogent Biosciences
COGT
$5.45B
$1.46M ﹤0.01%
37,637
-15,453
-29% -$541K
2025 Q4
2 quarters
TMO icon
3225
PUT
Thermo Fisher Scientific
TMO
$257B
$1.45M ﹤0.01%
+2,900
New +$1.39M
2026 Q2
0 quarters

Similar funds

John Overdeck's Q2 2026 Portfolio in Review

As of Q2 2026, John Overdeck held 5,589 positions worth $138B, up 11% from $124B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

John Overdeck withdrew a net $5.38B in Q2 2026, closing 572 positions and reducing 1,756 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Miscellaneous.

Against the trend, John Overdeck opened a new position in Intuit worth $564M.

  • John Overdeck's largest Q2 2026 buy was Intuit: 2,161,507 shares worth $564M.
  • John Overdeck added most to Boston Scientific in Q2 2026, an estimated $540M increase.
  • John Overdeck's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.32B.
  • John Overdeck fully exited State Street Technology Select Sector SPDR ETF in Q2 2026, selling an estimated $172M.
  • John Overdeck's ten largest holdings make up 8.3% of its $138B portfolio in Q2 2026.
  • John Overdeck opened 1,050 new positions and closed 572 in Q2 2026.
  • John Overdeck's portfolio value rose 11% quarter-over-quarter to $138B.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.